Diagnostic Cardiology at Baxter - U.S.
Joshua Oele is a seasoned sales professional with extensive experience in cardiac monitoring and account management. Currently serving as Senior Account Executive and Field Sales Trainer at Diagnostic Cardiology at Baxter since February 2021, Joshua has been recognized as the Associate Account Executive of the Year for 2021 and has consistently met and exceeded sales quotas from 2021 to 2023. Notable achievements include the development of a new territory resulting in 60 active accounts and effectively covering a high-performing vacant territory. Previous roles include Account Executive positions at Bardy Diagnostics and 1st Choice Financial Services, as well as a Territory Manager role overseeing business development functions. Joshua began a career in sales at Enterprise, where responsibilities included branch management and employee training. Joshua holds a Bachelor of Arts in Business Administration from Calvin University.
This person is not in any offices
Diagnostic Cardiology at Baxter - U.S.
1 followers
Bardy Diagnostics is a developer of a cardiac monitor and arrhythmia detection device. The company has created a new, state-of-the-art heart monitor known as Carnation Ambulatory Monitor (CAM) that can be worn comfortably and discreetly for up to 7 days. Unlike many other heart monitors, CAM can be worn during exercise or while showering. Itsunique, narrow, hourglass shape makes it especially advantageous for the female anatomy. It is also designed to be comfortable for women to wear, with its narrow, hourglass shape.Bardy Diagnostics uses his expertise to develop cardiac monitoring solutions that help physicians obtain more accurate information about actionable events in the hopes of saving lives. The company's mission is to improve clinical management and outcomes for patients and their physicians by employing innovative P-wave centric ECG detection into patient-friendly technologies that result in greater patient compliance and more confident physician diagnoses.Bardy Diagnostics was founded in 2013 and is headquartered in Seattle, Washington, USA.